Company Filing History:
Years Active: 2021
Title: Man-Ching Shen: Innovator in Mitochondrial Protection
Introduction
Man-Ching Shen is a notable inventor based in Zhubei, Taiwan. He has made significant contributions to the field of mitochondrial protection, particularly in relation to retinal health. His innovative work has led to the development of a unique pharmaceutical composition aimed at enhancing mitochondrial function in retinal cells.
Latest Patents
Man-Ching Shen holds a patent for a method that protects mitochondria in retinal cells. The patent, titled "Method for protecting mitochondria in retina cell," describes the use of an emblica extract in preparing a pharmaceutical composition. This composition is designed to improve the ability of retinal cells to perform oxidative phosphorylation for the synthesis of adenosine triphosphate (ATP) when exposed to ultraviolet light. The invention also enhances the coupling efficiency of ATP synthesis by mitochondria in these cells. He has 1 patent to his name.
Career Highlights
Man-Ching Shen is associated with Taiwan Mitochondrion Applied Technology Co., Ltd., where he continues to advance research in mitochondrial applications. His work is pivotal in developing therapeutic solutions for retinal health, showcasing his commitment to innovation in the biomedical field.
Collaborations
Some of his notable coworkers include Han-Chung Cheng and Chi-Tang Tu, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Man-Ching Shen's contributions to mitochondrial protection in retinal cells highlight his innovative spirit and dedication to improving health outcomes. His work exemplifies the impact of scientific research on real-world applications, particularly in the field of ophthalmology.